NCT00784888 - Research Of Quality Of Life And Safety Outcomes Of Postmenopausal Breast Cancer Patients Switching From Tamoxifen Therapy To Aromatase Inhibitor Therapy | Biotech Hunter

Enrollment

344

Participants

Timeline

Start Date

June 30, 2008

Primary Completion Date

December 31, 2011

Study Completion Date

December 31, 2011

Conditions

Breast Neoplasms

Interventions

OTHER

Aromatase inhibitors

non-interventional study

Trial Locations (16)

Pfizer Investigational Site, Istanbul

Pfizer Investigational Site, Izmir

Pfizer Investigational Site, Adana

Pfizer Investigational Site, Ankara

Pfizer Investigational Site, Ankara

Pfizer Investigational Site, Ankara

Pfizer Investigational Site, Bursa

Pfizer Investigational Site, Denizli

Pfizer Investigational Site, Edirne

Pfizer Investigational Site, Erzurum

Pfizer Investigational Site, Gaziantep

Pfizer Investigational Site, Istanbul

Pfizer Investigational Site, Izmir

Pfizer Investigational Site, Kocaeli

Pfizer Investigational Site, Malatya

Pfizer Investigational Site, Trabzon